Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 4:15 pm |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Financial Officer |
6,954 | $0.9837 | $6,841 | 321,546 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Option Award |
2025-04-16 4:30 pm |
N/A 2035-04-14 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2025-01-01 Exercise |
2025-01-03 4:15 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Financial Officer |
19,375 | $0 | 321,546 (Direct) |
View |
| 2025-01-01 Option Award |
2025-01-03 4:15 pm |
N/A 2035-12-31 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Financial Officer |
251,000 | $0 | 321,546 (Direct) |
View |
| 2024-08-03 Option Award |
2024-08-06 8:00 pm |
N/A 2034-08-02 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer |
52,000 | $0 | 52,000 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:10 pm |
N/A 2034-04-30 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER |
208,000 | $0 | 208,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 4:38 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER |
77,500 | $0 | 77,500 (Direct) |
View |
| 2023-08-16 Option Award |
2023-08-18 8:40 pm |
N/A 2033-08-15 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James CHIEF OPERATING OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-08-03 Option Award |
2023-08-07 4:12 pm |
N/A 2033-08-02 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
Ownership |
2023-08-07 4:09 pm |
N/A 2031-03-28 |
Xilio Therapeutics Inc. | XLO | Frankenfield Christopher James Chief Operating Officer |
0 | $0 | 398,172 (Direct) |
View |